-- title: "Leptospirosis in Dogs: Clinical Signs, Diagnosis, and Updated Vaccination Protocols" category: "symptom-guides" metaDescription: "A comprehensive veterinary reference on canine leptospirosis covering clinical manifestations, diagnostic strategies including serovar-specific PCR and MAT testing, and updated vaccination protocols emphasizing Icterohaemorrhagiae and Canicola serogroups." primaryKeyword: "leptospirosis in dogs" secondaryKeywords: ["canine leptospirosis clinical signs", "leptospirosis diagnosis dog", "serovar-specific PCR", "MAT testing leptospira", "leptospirosis vaccination protocols Icterohaemorrhagiae Canicola"]

Leptospirosis in Dogs: Clinical Signs, Diagnosis, and Updated Vaccination Protocols

Introduction

Leptospirosis is a globally significant bacterial disease of dogs caused by pathogenic spirochetes of the genus Leptospira. These bacteria are maintained in the environment through chronic renal carriage in reservoir hosts, including rodents, wild mammals, and domestic livestock. Transmission to dogs occurs via direct contact with infected urine or indirect exposure through contaminated water, soil, or fomites. The disease has a worldwide distribution, with incidence influenced by meteorological factors such as rainfall, temperature, and flooding [2]. Epidemiological studies from diverse geographic regions underscore the importance of understanding local serovar prevalence to guide diagnostic and preventive strategies [6, 7, 15].

Infection in dogs can result in a spectrum of clinical outcomes, from subclinical carriage to fulminant multisystemic disease. The most common clinical presentations involve acute renal failure and hepatic dysfunction, often accompanied by coagulopathies and pulmonary involvement. Diagnosis relies on a combination of serological and molecular methods, with the microscopic agglutination test (MAT) and polymerase chain reaction (PCR) serving as the principal diagnostic tools. Vaccination remains the cornerstone of prevention, with current bacterin vaccines targeting serogroups Icterohaemorrhagiae and Canicola, though regional formulations may include additional serogroups such as Pomona, Grippotyphosa, and Australis. This article provides a detailed, evidence-based review of the clinical signs, diagnostic approaches, and updated vaccination protocols for canine leptospirosis, drawing on recent peer-reviewed literature.

Clinical Signs and Pathophysiology

The incubation period for leptospirosis in dogs typically ranges from 5 to 14 days. After penetration through mucous membranes or abraded skin, leptospires disseminate hematogenously, seeding target organs including the kidneys, liver, lungs, and eyes. The host immune response, particularly the production of IgM and subsequently IgG antibodies, contributes to tissue damage through immune complex deposition and direct bacterial cytotoxicity.

Renal Manifestations

Acute renal failure is the hallmark of canine leptospirosis, resulting from interstitial nephritis and tubular necrosis. Clinical signs include polyuria, polydipsia, vomiting, lethargy, and anorexia. Oliguric or anuric renal failure carries a guarded prognosis. Laboratory findings include azotemia (elevated blood urea nitrogen and creatinine), hyperphosphatemia, and isosthenuria. Urinalysis often reveals proteinuria, granular casts, and hematuria. The differential diagnosis for acute renal failure in dogs includes ethylene glycol toxicity, ingestion of toxic plants, Canine Adenovirus 1 infection causing infectious canine hepatitis, and Canine Parvovirus variants that can cause secondary renal damage. Additionally, Xylitol Toxicology must be considered in cases of acute hepatorenal syndrome.

Hepatic and Pulmonary Involvement

Hepatic disease manifests as icterus, elevated liver enzymes, and bilirubinuria. Leptospires induce hepatocellular necrosis and cholestasis. Pulmonary involvement, characterized by pulmonary hemorrhage and acute respiratory distress syndrome, is a life-threatening complication. A serial evaluation of pulmonary changes in dogs with leptospirosis documented progressive alveolar infiltration, consolidation, and ventilation-perfusion mismatch, emphasizing the need for early thoracic imaging and oxygen support [1].

Coagulation Disorders and Other Signs

Thrombocytopenia, prolonged clotting times, and petechiation are common due to vasculitis and consumptive coagulopathy. Ocular signs, including uveitis and conjunctival suffusion, may occur but are more frequently associated with chronic infection. Neurologic signs due to meningoencephalitis are rare but documented.

The following table summarizes clinical signs by organ system:

Diagnosis of Canine Leptospirosis

Accurate diagnosis requires integration of signalment, history, clinical signs, and laboratory testing. The two primary diagnostic modalities are serology and PCR. Culture and dark-field microscopy have limited sensitivity and are rarely used in clinical practice.

Serology: Microscopic Agglutination Test (MAT)

The MAT is the reference standard for serodiagnosis and serovar identification. The test detects antibodies against live leptospiral serovars, with a titer of 1:100 or greater considered positive in non-vaccinated dogs, and 1:800 or greater in vaccinated dogs to indicate active infection. However, MAT has several limitations: it requires paired acute and convalescent samples for definitive diagnosis, it cross-reacts among serogroups, and it cannot distinguish between vaccination and natural infection. Recent studies highlight the value of serovar-specific MAT interpretation in outbreak investigations and epidemiological surveys [3, 13].

Molecular Diagnostics: Polymerase Chain Reaction (PCR)

PCR, particularly targeting the lipL32 or secY genes, provides rapid detection of pathogenic Leptospira in blood, urine, or tissue samples. PCR is most sensitive during the first 7 to 10 days of illness (blood) and can remain positive in urine for weeks to months after infection. Serovar-specific PCR assays, such as those discriminating between Icterohaemorrhagiae, Canicola, Pomona, Grippotyphosa, and Australis, have been developed and applied in outbreak settings to guide public health interventions [3, 9, 11]. Additionally, genomic comparisons of Leptospira interrogans isolates from dogs, humans, and wildlife have provided insights into host tropism and transmission dynamics [10].

Additional Diagnostic Tests

Commercial enzyme-linked immunosorbent assay (ELISA) kits can detect anti-leptospiral IgM and IgG antibodies and are used as screening tools, but they lack serovar specificity. Biomarkers such as serum sialic acid have been investigated as indicators of inflammation and infection, though their diagnostic utility in leptospirosis remains under evaluation [4]. Novel diagnostic platforms, including lateral flow assays using recombinant antigens (e.g., Loa22) conjugated to gold nanoparticles, are being developed for rapid point-of-care serodiagnosis in dogs and cattle [12].

Differential Diagnosis of Acute Renal Failure

Distinguishing leptospirosis from other causes of acute renal failure is critical. The following table lists key differential diagnoses:

The diagnostic workflow for suspected leptospirosis is represented in the following Mermaid diagram:

graph TD
    A[Clinical suspicion: fever, vomiting, jaundice, oliguria], > B[Collect blood and urine]
    B, > C{Initial testing}
    C, > D[Complete blood count, chemistry panel, urinalysis]
    D, > E[Azotemia, elevated liver enzymes, thrombocytopenia?]
    E, >|Yes| F[Perform MAT and PCR]
    E, >|No| G[Consider alternative diagnoses]
    F, > H{MAT titer >=1:800 or PCR positive?}
    H, >|Yes| I[Confirmed leptospirosis]
    I, > J[Initiate antibiotic therapy: doxycycline or penicillin derivatives]
    J, > K[Supportive care: IV fluids, dialysis if needed, oxygen support]
    K, > L[Assess vaccination history]
    L, > M[Vaccinate after recovery with multivalent bacterin]
    H, >|No| N[Repeat MAT in 2-4 weeks if high suspicion]
    N, > O{Titer rise?}
    O, >|Yes| I
    O, >|No| G

Updated Vaccination Protocols

Vaccination is the most effective strategy to reduce morbidity and mortality from leptospirosis in dogs. Current vaccines are bacterins containing inactivated whole-cell Leptospira antigens. They confer serogroup-specific immunity and require regular boosters. The core serogroups targeted in most commercial vaccines are Icterohaemorrhagiae and Canicola, as these are historically the most prevalent and virulent in dogs. However, regional epidemiological data have led to the inclusion of additional serogroups. For example, in North America, vaccines containing Pomona and Grippotyphosa are widely recommended due to their emergence in canine outbreaks [3, 8].

Vaccine Efficacy and Duration of Immunity

Bacterin vaccines reduce the incidence of clinical disease but do not prevent infection or renal carriage. The duration of immunity is estimated at 12 to 14 months, necessitating annual revaccination in most protocols. Some authorities recommend risk-based intervals, for instance, every 6 to 9 months for dogs with high exposure (e.g., hunting dogs, dogs in kennels, dogs living in endemic areas). A study examining the risk of infection in dogs exposed to clinical leptospirosis cases found that unvaccinated contact dogs were significantly more likely to develop disease, reinforcing the importance of vaccination in outbreak control [8].

Vaccine Serogroup Selection

Selection of vaccine serogroups should be guided by local seroprevalence data. Recent molecular and serological surveys have identified serogroups Icterohaemorrhagiae and Canicola as dominant in many regions, but significant variability exists [5, 6, 7, 13, 15]. For instance, a study in the Yangtze River region of China reported high prevalence of serogroup Australis [13], while investigations in Thailand and Colombia documented circulation of serogroups not always included in commercial vaccines [9, 11]. Veterinarians should consult regional surveillance data and consider using vaccines that cover the locally relevant serogroups.

Vaccination Schedule

The typical vaccination protocol for puppies begins at 8 to 9 weeks of age, with a second dose 3 to 4 weeks later, followed by a booster at 6 months and then annually. For adult dogs with no prior vaccination history, two doses 3 to 4 weeks apart are administered, followed by annual boosters. Pregnant or immunocompromised dogs should receive killed vaccines only, and data on safety in these groups are limited. Adverse reactions, including anaphylaxis, are rare but can occur, particularly in small breed dogs.

The following table summarizes key vaccination considerations:

Conclusions

Canine leptospirosis remains a challenging infectious disease with diverse clinical presentations, primarily acute renal failure and hepatic dysfunction. Diagnosis relies on paired MAT serology and PCR assays, with emerging serovar-specific molecular tools enhancing outbreak investigations. Vaccination targeting serogroups Icterohaemorrhagiae and Canicola, with extension to other regional serogroups, is essential for disease prevention. Veterinarians must integrate epidemiological data, clinical acumen, and laboratory diagnostics to effectively manage and control this zoonotic infection.

References

1. Bringold C, Schweighauser A, Walther S et al. Serial evaluation of clinical, functional, and structural pulmonary changes in 10 dogs with leptospirosis. J Vet Intern Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42224492/

2. Hobson SJ, Zai B, Vyn CM et al. Impacts of meteorological factors on zoonotic infections in domestic cat and dog populations: A scoping review of international evidence. One Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42211529/

3. Randolph MW, Nally JE, Yoshimoto SK et al. Clinical and molecular characterization of an outbreak of leptospirosis in dogs from Los Angeles County, California, USA, 2021. J Clin Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42189535/

4. Yaghoobpour T, Faraji M, Nazifi S. Serum Sialic Acid as a Biomarker of Inflammation and Infection: Insights From Veterinary Medicine. Vet Med Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42148179/

5. Patiño-Gómez S, Naranjo-Vargas LF, Aguirre-Acevedo DC et al. Epidemiological study of leptospiral interaction in bovine farms in rural areas of Colombia: A One Health approach. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42090421/

6. Wei W, Jiao D, Dong X et al. Epidemiology and associated factors of human and canine leptospirosis in China: a systematic review and meta-analysis. Prev Vet Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864068/

7. Galvão CMMQ, Leite DPSBM, Oliveira PRF et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni-ô Indigenous community in Pernambuco, Brazil: a One Health perspective. Braz J Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41849483/

8. Skinner VJ, Ward MP, Griebsch C. Risk of infection in dogs in contact with clinical canine leptospirosis cases. Aust Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41814781/

9. Thongdee M, Chaiwattanarungruengpaisan S, Paungpin W et al. Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41637464/

10. Kakita T, Takabe K, Morita M et al. Genomic comparison of Leptospira interrogans isolated from humans, dogs, and wild and feral animals in Japan. Int J Med Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41579465/

11. Beltrán-Sánchez CA, Bettin AC, Castellanos-Romero K et al. Molecular surveillance of Leptospira infection in domestic dogs in Soledad, Northern Colombia. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41557245/

12. Gautam H, Kumar BVS, Singh S et al. Evaluation of a recombinant Loa22-gold nanoparticle based lateral flow assay for the serodiagnosis of leptospirosis in canine and bovine. Arch Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41524783/

13. Ding Y, Zhang S, Zhang W et al. Seroprevalence and Molecular Epidemiology of Leptospira spp. Infecting Dogs in the Yangtze River Region of China. Transbound Emerg Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41383393/

14. Jost HE, Henriksen ML, Hawley J et al. Evaluation of Leptospira species as a cause of endogenous uveitis in cats: a pilot study. J Feline Med Surg. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41378760/

15. Andrade-Silveira E, Segura-Correa JC, Ortega-Pacheco A et al. Seroprevalence of pathogenic leptospira in domiciled and stray dogs from subtropical Mexico. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41359150/